FEATURES OF THE FUNCTIONAL STATE OF MUSCLE TISSUE IN ELDERLY PATIENTS WITH URGENT SURGICAL PATHOLOGY

Rasenko Andrii

doi:10.31435/rsglobal_ws/28022021/7440

Rasenko Andrii Postgraduate student, Kharkiv national medical university, Kharkiv, Ukraine https://orcid.org/0000-0001-6932-4300

DOI: https://doi.org/10.31435/rsglobal_ws/28022021/7440

Keywords: sarcopenia, metabolic disorders, levocarnitine, intensive therapy, sarcopenia, metabolic disorders, levocarnitine, intensive therapy

Abstract

Sarcopenia is an important factor in the occurrence of complications in elderly patients with urgent surgical pathology. Decreased muscle strength and function is an important criterion for impaired early activation of such patients, which increases the number of complications and length of stay in the clinic. Identification of functional disorders of muscle tissue, as well as other metabolic disorders, such as type 2 diabetes, disorders of lipid metabolism, is important for the appointment of an adequate complex of intensive care. Prescribing levocarnitine and D-fructose-1,6-diphosphate sodium salt of hydrate is an important part of the treatment program in such patients.

References

Jeejeebhoy K.N. Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features // Curr. Opin. Clin. Nutr. Metab. Care. 2012. Vol. 15. № 3. P. 213–219.

Kalyani, R.R. Hyperglycemia is associated with the incidence of frailty and lower extremity mobility limitations in older women / R.R. Kalyani, J. Tian, Q-L. Xue, J. Walston et al. // J Am Geriatr Soc. – 2012. – V.60. – P. 1701–1707.

Kelley, G. A., & Kelley, K. S. (2017). Is sarcopenia associated with an increased risk of all-cause mortality and functional disability?. Experimental gerontology, 96, 100–103. https://doi.org/10.1016/j.exger.2017.06.008

Koo, B.K. Difference between old and young adults in contribution of β-cell function and sarcopenia in developing diabetes mellitus / B.K. Koo, E. Roh, Y.S. Yang, M.K. Moon // J. Diabetes Investig. – 2016. – V.7. – P. 233–240.

Kulkarni, A.S. Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults / A.S. Kulkarni, E.F. Brutsaert, V. Anghel et al. // Aging Cell. – 2018. V.17. – Aging Cell. DOI: 10.1111/acel.12723.

Marcell, T.J. Sarcopenia: causes, consequences and preventions / T.J. Marcell //The journals of gerontology. Series A, Biological sciences and medical sciences. – 2003. – V.58A. - M 911-916. 152. Martin-Montalvo A. et al. Metformin improves healthspan and lifespan in mice //Nature communications. – 2013. – V. 4. – P. 2192.

Pereira R. A. et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality //Nephrology Dialysis Transplantation. – 2015. – V. 30. – №. 10. – P. 1718-1725.

Perkisas, S. Where frailty meets diabetes / S. Perkisas, M. Vandewoude // Diabetes Metab Res Rev. – 2016. – V. 32 (Suppl 1). – P. 261–267.

Rena G., Hardie D. G., Pearson E. R. The mechanisms of action of metformin //Diabetologia. – 2017. – V. 60. – №. 9. – P. 1577-1585.

Shafiee G. et al. Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies //Journal of Diabetes & Metabolic Disorders. – 2017. – V. 16. – №. 1. – P. 21.

Shah, N.R. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin / N.R. Shah, E.R. Braverman // PLoS ONE. – 2012. –V.7. - e33308.

Sharples, A.P., Hughes, D.C., Deane, C.S., Saini, A., Selman, C. and Stewart, C.E. (2015), Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intake. Aging Cell, 14: 511-523. https://doi.org/10.1111/acel.12342

Yanase, T. Frailty in elderly diabetes patients / T. Yanase, Ikumi Yanagita, Kazuo Muta, Hajime Nawata // Endocrine journal. – 2018. – V. 65 - Issue 1. – P. 1-11.

Yu, Ruby. Incremental Predictive Value of Sarcopenia for Incident Fracture in an Elderly Chinese Cohort: Results from the Osteoporotic Fractures in Men (MrOs) Study / R. Yu. // J. Am. Med. Dir. Assoc: JAMDA. – 2014. – V.XXX. – P. 1-8.